Geneos Wealth Management Inc. Cellectis S.A. Transaction History

Geneos Wealth Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.45 - $8.77 $34,500 - $87,700	-10,000 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$8.01 - $12.84 $80,100 - $128,400	10,000 New	10,000 $81,000
Q3 2021 Nov 09, 2021	SELL	$11.94 - $16.09 $89,191 - $120,192	-7,470 Closed	0 $0
Q2 2021 Jul 08, 2021	SELL	$14.36 - $20.93 $132,672 - $193,372	-9,239 Reduced 55.29%	7,470 $113,000
Q1 2021 Jun 17, 2021	BUY	$18.19 - $33.25 $48,658 - $88,943	2,675 Added 19.06%	16,709 $310,000
Q4 2020 May 19, 2021	BUY	$15.87 - $31.64 $222,719 - $444,035	14,034 New	14,034 $64,000
Q3 2016 Sep 07, 2021	SELL	N/A	-247 Closed	0 $0
Q1 2016 Sep 07, 2021	BUY	N/A	247	247 $6,000

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $82.8M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.